SR18662 |
| Catalog No.GC39754 |
Le SR18662 est un puissant inhibiteur du facteur cinq de type KrÜppel (KLF5) avec une IC50de 4,4nM et un analogue du ML264 avec un pouvoir inhibiteur amélioré contre les cellules cancéreuses colorectales. SR18662 peut être utilisé pour l'étude du cancer colorectal.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2505001-62-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
SR18662 is a potent inhibitor of KrÜppel-like factor five (KLF5) with an IC50 of 4.4 nM, an analogue of ML264 with improved inhibitory potency against colorectal cancer cells. SR18662 can be used for the study of colorectal cancer[1].
[1]. Julie Kim,et al.The Novel Small-Molecule SR18662 Efficiently Inhibits the Growth of Colorectal Cancer In Vitroand In Vivo.Mol Cancer Ther.2019 Nov;18(11):1973-1984.
Average Rating: 5 (Based on Reviews and 11 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *